Global
Bladder Cancer Market - Overview
The global bladder
cancer market size is projected to grow USD 8.2 billion by 2032, exhibiting a
CAGR 4.60% during the forecast year 2023-2032. growing at a steady pace. This
can be attributed to increasing prevalence of bladder cancer. It is reported
that the exact cause of the bladder cancer is not clear, however, the medical
condition is estimated to be aaocaited with certain
factors which are inclusive mutations in the genetic composition of the
patients, continuous exposure to harmful radiations, and adoption of unhealthy
lifestyle. Such conditions are responsible for
increasing the reported cases of bladder cancer across the globe. Moreover,
factors such as increasing government support alongwith the growing investment
in the research and development procees boosts the market growth.
Adfditionally, rising awareness regarding the medical condition among the masses
also contributs to the market growth. However, there factors such as high cost of the treatment in terms of expensive
drugs, and related side effects are estimated to restarin the market tgrowth
during the projected period.
Global
Bladder Cancer Market - Competitive Analysis
The market for bladder cancer is well
established market with number of companies operating in this market.
The global bladder
cancer market players such as, Oncogenex (US),
Astellas (Japan), Eli Lilly and Company (US), AstraZeneca (UK), F. Hoffmann-La
Roche (Switzerland), GlaxoSmithKline (UK), Accord Healthcare, Inc.(India), Pfizer
(US), Novartis AG (Switzerland) Bristol-Myers Squibb company (US) and others. These
are some of the major market players at the forefront of competition in the global
bladder cancer market.
Bladder Cancer
Market is expected to grow in the presence of increasing demands for better
rtherapeutics. Currently, the market is witnissing an unavailability of absolute
treatment. This can be seen as an for the market players to expand their market.
The players, present in the global bladder
cancer market are focusing on the development of new products. Such novel products are being designed with views of cost
effectiveness and minimum side effects. Therefore, many companies in the market
are involved in the development of specific types of molecules, and novel
therapies have adopted the strategies of the acquisitions, product launches in
order to strive in the competitive market. Additionally,
competition amongst new entrants is expected to increase the growth for bladder
cancer market over the forecasted period.
Global
Bladder Cancer Market - Regional Analysis
On the basis of
the geography, the global bladder
cancer market insights is segmented into the four major regions, namely the
Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas holds
the largest share in the global bladder cancer market. Presence of huge patient population suffering
from bladder cancer is a major reason behind the same. As per the American
Cancer Society, approximately 79,030 new cases of bladder cancer were reported in 2017. Moreover, it was estimated that the
disease caused about 16,870 deaths withihn the U.S. Additionally, factors includfing
changing lifestyle, rising government support, incrteasing role of cancer care
organisations for incraesing the awareness s also impacts a positive growth in the global bladder cancer market.
Europe accounts
for the second largest market share for the bladder cancer, which is followed by Asia
Pacific. Asia Pacific is the fastest growing market owing to the huge
population base, increasing prevalence of bladder cancer, rapidly developing
economies and presence of huge opportunity for the growth of the market. The
Middle East & Africa has the least market share due to the unavailability
of the required healthcare infrastructure, lack of awareness among people, and
affordability issues due to presence of the poor economies in Africa region.
Market Research Future (MRFR),
enable customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part
of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor,
New York,
New York 10013
United States of America
